Allergan Botox 100iu Injection

Nabota Botulinum Toxin Type A

Nabota 100 units is a botulinum toxin type A made by Daewoong Pharmaceutical Co., Ltd., which accepted the product through the U.S. Food and Drug Administration. It was the very first Korean botulinum toxin that entered the U.S. market. Nabota is a direct competitor to Botox because it's an affordable alternative that does not require altering how you manage this toxic substance. The Nabota series consists of two items: Nabota 100ui.
What are the benefits of Nabota?

Botulinum Toxin Type A (NABOTA) is indicated for the treatment of spasmodic torticollis (cervical dystonia) in adults. Botulinum Toxin Type A (NABOTA) is indicated for the treatment of dynamic equinus foot deformity due to spasticity in pediatric cerebral palsy patients, two years of age or older.